Cepheid clinical trials
Acquired by Danaher Corporation, Nov 4, 2016 · source ↗
The registry lists 10 studies whose lead sponsor is Cepheid. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated May 18, 2026.
Before and after it joined Danaher Corporation
- First submitted before Cepheid became part of Danaher Corporation
- 2
- First submitted after Cepheid became part of Danaher Corporation
- 8
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Cepheid10 studies
Something wrong with this grouping? Tell us on the Danaher Corporation page.
Studies
Recruiting first, then most recently updated. Showing 10 of 10. All Danaher Corporation studies →
- Xpert® Tropical Fever Test on GeneXpert® Edge X SystemEnrolling by invitationNCT07520279
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- Xpert Hemorrhagic Fever on Edge X in Trained and Untrained UsersCompletedNCT07591740
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- Xpert® ERP on the GeneXpert® SystemCompletedNCT07489846
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- Xpert® Hemorrhagic Fever on the GeneXpert® Edge X SystemCompletedNCT07370454
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- Xpert Hepatitis-C Virus (HCV) Test on the GeneXpert Xpress SystemCompletedNCT06508996
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- A Multi-National Study In Bladder Cancer Patients to Detect Recurrences After TURB (Trans-urethral Resection of the Bladder) Earlier With the Xpert Bladder Cancer Monitor Assay (ANTICIPATE X)CompletedNCT03664258
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- Clinical Evaluation of a Test for Monitoring the Recurrence of Bladder CancerCompletedNCT03125460
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML)CompletedNCT03421626
Sponsor listed in the registry: Cepheid · First submitted after Cepheid became part of Danaher Corporation
- Clinical Evaluation of the Xpert® HIV-1 VLCompletedNCT02461576
Sponsor listed in the registry: Cepheid · First submitted before Cepheid became part of Danaher Corporation
- Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis SuspectsCompletedNCT01587469
Sponsor listed in the registry: Cepheid · First submitted before Cepheid became part of Danaher Corporation